Nephrectomy Offers Potential PFS Benefit in mRCC Who Underwe

Nephrectomy was associated with a progression-free survival (PFS) benefit compared with immunotherapy alone in patients with metastatic renal cell carcinoma who received immunotherapy.

Related Keywords

China , Nanchang , Jiangxi , , First Affiliated Hospital Of Nanchang University , Rcc Database Consortium , First Affiliated Hospital , Nanchang University , Jiangxi Cancer Hospital , Jiangxi Provincial People , Immunotherapy In Gu Cancers , Immuno Oncology , News , Genitourinary Cancers , Gu Cancer , Mrcc , Metastatic Renal Cell Carcinoma , Bmc Cancer ,